欧美激情A∨在线视频播放,久久精品亚洲Av无码四区,日本精品αv中文字幕,免费一级毛片在线观看

HFCIM Awarded as “National Intellectual Property Advantage Enterprise 2022”

2022-10-20 01:38:09

Recently, the National Intellectual Property Administration released the list of "2022 National Intellectual Property Advantage Demonstration Enterprises". HFCIM has been honored as the "National Intellectual Property Advantage Enterprise" for the year 2022. This recognition comes as a result of the HFCIM's outstanding performance in intellectual property. Following the success in winning gold and silver at the 2021 China Patent Award, this new national-level honor signifies a further advancement in HFCIM's comprehensive capabilities in intellectual property creation and management.

國家知識產(chǎn)權示范企業(yè).png


"National Intellectual Property Advantage Enterprise" refers to enterprises that belong to key development industries at the national and municipal levels. These enterprises are capable of undertaking significant and key projects in national and local industrial development and possess independent intellectual property capabilities, actively engage in intellectual property protection and utilization, establish comprehensive intellectual property management systems and mechanisms, and demonstrate overall strength in intellectual property.

Since its establishment, HFCIM has adhered to the principle of "driving the continuous development of the company with intellectual property." HFCIM has conducted a full-chain approach to intellectual property creation, protection, utilization, and management.  As of now, HFCIM has applied for nearly 400 patents and has been granted over 200 patents. In addressing common technologies within the industry, HFCIM has refined advanced standards, leading the development of one international standard, two national standards, 25 provincial local standards, and over 20 other standards.

屏幕截圖 2022-10-13 204614.png

The honor is an affirmation and support from various levels of regulatory authorities for HFCIM's technological innovation and intellectual property efforts. In the future, HFCIM will continue to increase R&D investment, develop homemade proton therapy systems, establish an international leading research and manufacturing center for nuclear medicine equipment.


Go back to the previous page
灵璧县| 湘乡市| 贞丰县| 拉萨市| 大城县| 蒙山县| 永年县| 乐都县| 浑源县| 汤阴县| 祥云县| 曲周县| 磐石市| 镇安县| 开鲁县| 德兴市| 堆龙德庆县| 罗甸县| 吉木萨尔县| 综艺| 武威市| 昆山市| 玉溪市| 五大连池市| 五大连池市| 遵义市| 会东县| 绥化市| 徐闻县| 邓州市| 阜康市| 富阳市| 肇源县| 南充市| 太保市| 贡觉县| 湘乡市| 皮山县| 浦江县| 长乐市| 江川县|